Ascentage Pharma Group International (OTCMKTS:ASPHF) Short Interest Up 80.5% in December

Ascentage Pharma Group International (OTCMKTS:ASPHF) saw a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 1,550,100 shares, an increase of 80.5% from the December 15th total of 858,900 shares. Based on an average trading volume of 900 shares, the short-interest ratio is presently 1,722.3 days.

Ascentage Pharma Group International Stock Performance

Shares of Ascentage Pharma Group International stock opened at $6.45 on Wednesday. Ascentage Pharma Group International has a 1 year low of $6.45 and a 1 year high of $6.45. The business has a 50 day moving average price of $6.45 and a 200 day moving average price of $4.36.

About Ascentage Pharma Group International

Ascentage Pharma Group International, a clinical-stage biotechnology company, engages in developing therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in the United States and Mainland China. Its primary product HQP1351, a BCR-ABL inhibitor targeting BCR-ABL mutants, including those with the T315I mutation.